AstraZeneca ensures clinical research is registered according to all global requirements:
We register studies on other websites globally within timelines as required by country laws.
In the US, we register the following on the US National Library of Medicine’s website:
Phase 1 to 4 interventional trials
U.S. Early Access Programs
Observational trials involving AZ drug, or even studies between non-AZ drug and other treatment options for clinical outcomes
Post Authorization Safety studies
In the EU, we register all phase 1-4 trials that are conducted in European Economic Area (EEA) on European Union Clinical Trial Registry or the new EU Clinical Trial information System (CTIS), prior to the first patient being enrolled in a trial.
All AstraZeneca sponsored interventional and above mentioned observational clinical trials are listed on our dedicated clinical trials website, astrazenecaclinicaltrials.com.